APA (7th ed.) Citation

J, Z., X, D., W, W., H, J., & L, T. (2026). Higher lymph node burden predicts greater chemotherapy benefit in resected pancreatic ductal adenocarcinoma: Evidence from 22,045 patients. Scientific reports, 16(1), . https://doi.org/10.1038/s41598-026-36035-x

Chicago Style (17th ed.) Citation

J, Zhou, Dou X, Wei W, Jiang H, and Tang L. "Higher Lymph Node Burden Predicts Greater Chemotherapy Benefit in Resected Pancreatic Ductal Adenocarcinoma: Evidence from 22,045 Patients." Scientific Reports 16, no. 1 (2026). https://doi.org/10.1038/s41598-026-36035-x.

MLA (9th ed.) Citation

J, Zhou, et al. "Higher Lymph Node Burden Predicts Greater Chemotherapy Benefit in Resected Pancreatic Ductal Adenocarcinoma: Evidence from 22,045 Patients." Scientific Reports, vol. 16, no. 1, 2026, https://doi.org/10.1038/s41598-026-36035-x.